EUVIMEDEUVIMED entdecken
Crossref

Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine–Topiramate to Prevent Exposure During Pregnancy

Amir Sarayani iD, William Troy Donahoo iD, Christian Hampp iD, Joshua D Brown, Almut G Winterstein iD

Annals of Internal Medicine · 2023

DOI: 10.7326/m22-1743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von Amir Sarayani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, and Center for Drug Safety and Evaluation, University of Florida, Gainesville,…. Hauptthemen laut MEDLINE: Prenatal Exposure Delayed Effects, Anti-Obesity Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prenatal Exposure Delayed EffectsAnti-Obesity AgentsFemaleHumansPregnancyTopiramatePhentermineRetrospective StudiesRisk Evaluation and MitigationWeight LossObesityContraceptive AgentsFructose

Substanzen

TopiramatePhentermineAnti-Obesity AgentsContraceptive AgentsFructose

Autor:innen und Institutionen

  • Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, and Center for Drug Safety and Evaluation, University of Florida, Gainesville, Florida (A.S., J.D.B., A.G.W.).
  • Division of Endocrinology, Diabetes & Metabolism and Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida (W.T.D.).
  • Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, and Regeneron Pharmaceuticals, Inc., Tarrytown, New York (C.H.).

ORCID-Profile: Amir Sarayani, William Troy Donahoo, Christian Hampp, Almut G Winterstein

Zitieren

APA

Sarayani, A., Donahoo, W. T., Hampp, C., Brown, J. D., & Winterstein, A. G. (2023). Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine–Topiramate to Prevent Exposure During Pregnancy. Annals of Internal Medicine. https://doi.org/10.7326/m22-1743

Vancouver

Sarayani A, Donahoo WT, Hampp C, Brown JD, Winterstein AG. Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine–Topiramate to Prevent Exposure During Pregnancy. Annals of Internal Medicine. 2023. doi:10.7326/m22-1743

BibTeX
@article{Sarayani2023,
  author = {Sarayani, Amir and Donahoo, William Troy and Hampp, Christian and Brown, Joshua D and Winterstein, Almut G},
  title = {Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine–Topiramate to Prevent Exposure During Pregnancy},
  journal = {Annals of Internal Medicine},
  year = {2023},
  doi = {10.7326/m22-1743}
}
Kostenlos starten →